QuickView for YDL134C;jsessionid=BD58E30995E8BC2A228117A3FB93C314;jsessionid=E7C4FCCF0A3120B6C8A4A5493B8704BF;jsessionid=6053E70BD76ACEA6787887C0FE6942A9;jsessionid=2E84A94D4E4B153BC5CBCBCD27D68633;jsessionid=C5D67A11786F641691670FA481EEA953;jsessionid=5B52940807BC66E23F6A37F4E71C4467;jsessionid=E58C411A1A99C4B7E1493654B42DA945;jsessionid=39DDF2291CEBE2CA8696558E23002EBA;jsessionid=9E3BA1F26A192BB7D3ADAFE6592227FF;jsessionid=7ABED379E7E80B964F28C39A891C2C38 (gene)

1. The protein phosphatase Siw14 controls caffeine-induced nuclear localization and phosphorylation of …
2. PP2A-C may be a promising candidate for postmortem interval estimation.
3. c-Src inhibitor PP2 inhibits head and neck cancer progression through regulation of the epithelial-m…
4. PP2 protects from keratin mutation-associated liver injury and filament disruption via SRC kinase in…
5. PP2 Ameliorates Renal Fibrosis by Regulating the NF-κB/COX-2 and PPARγ/UCP2 Pathway in Diabetic Mice…

There were no clinical trials for YDL134C;jsessionid=BD58E30995E8BC2A228117A3FB93C314;jsessionid=E7C4FCCF0A3120B6C8A4A5493B8704BF;jsessionid=6053E70BD76ACEA6787887C0FE6942A9;jsessionid=2E84A94D4E4B153BC5CBCBCD27D68633;jsessionid=C5D67A11786F641691670FA481EEA953;jsessionid=5B52940807BC66E23F6A37F4E71C4467;jsessionid=E58C411A1A99C4B7E1493654B42DA945;jsessionid=39DDF2291CEBE2CA8696558E23002EBA;jsessionid=9E3BA1F26A192BB7D3ADAFE6592227FF;jsessionid=7ABED379E7E80B964F28C39A891C2C38